Page 8 of 11
Fatal serious side effects:
Non-fatal serious side effects:
Part 1:
Non-fatal serious side effects were reported by 2 participants (29%) in Group 1A and
4 participants (57%) in Group 1B. The non-fatal serious side effect reported by two or more
participants was decrease in a type of blood cell that help stop bleeding in one participant
(14%) in Group 1A and three participants (43%) in Group 1B.
Part 2:
Non-fatal serious side effects were reported by 12 participants (23%) in Group 2A and
11 participants (20%) in Group 2B. The non-fatal serious side effects reported by two or
more participants in either group are shown below.